JP2001516569A5 - - Google Patents

Download PDF

Info

Publication number
JP2001516569A5
JP2001516569A5 JP2000511779A JP2000511779A JP2001516569A5 JP 2001516569 A5 JP2001516569 A5 JP 2001516569A5 JP 2000511779 A JP2000511779 A JP 2000511779A JP 2000511779 A JP2000511779 A JP 2000511779A JP 2001516569 A5 JP2001516569 A5 JP 2001516569A5
Authority
JP
Japan
Prior art keywords
mammaglobin
antigen
seq
isolated
purified polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000511779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516569A (ja
Filing date
Publication date
Priority claimed from US08/933,149 external-priority patent/US5922836A/en
Application filed filed Critical
Publication of JP2001516569A publication Critical patent/JP2001516569A/ja
Publication of JP2001516569A5 publication Critical patent/JP2001516569A5/ja
Pending legal-status Critical Current

Links

JP2000511779A 1997-09-18 1998-09-18 ママグロビン、分泌された乳腺‐特異乳癌タンパク質 Pending JP2001516569A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/933,149 1997-09-18
US08/933,149 US5922836A (en) 1995-05-31 1997-09-18 Mammaglobin antigens
PCT/US1998/017991 WO1999014230A1 (en) 1997-09-18 1998-09-18 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (2)

Publication Number Publication Date
JP2001516569A JP2001516569A (ja) 2001-10-02
JP2001516569A5 true JP2001516569A5 (enExample) 2006-01-05

Family

ID=25463453

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000511779A Pending JP2001516569A (ja) 1997-09-18 1998-09-18 ママグロビン、分泌された乳腺‐特異乳癌タンパク質

Country Status (16)

Country Link
US (1) US5922836A (enExample)
EP (1) EP1037901A4 (enExample)
JP (1) JP2001516569A (enExample)
KR (1) KR20010030617A (enExample)
CN (1) CN1277614A (enExample)
AU (1) AU735338B2 (enExample)
BR (1) BR9812472A (enExample)
CA (1) CA2304167A1 (enExample)
HU (1) HUP0004022A2 (enExample)
IL (1) IL134998A0 (enExample)
NO (1) NO20001358L (enExample)
NZ (1) NZ503729A (enExample)
PL (1) PL340689A1 (enExample)
TR (2) TR200003685T1 (enExample)
WO (1) WO1999014230A1 (enExample)
ZA (1) ZA988526B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2971700A (en) * 1999-01-21 2000-08-07 Wayne State University Method and apparatus for measuring factors in mammary fluids
AU4469400A (en) * 1999-04-20 2000-11-02 Zymogenetics Inc. Zalpha13: a human secreted protein
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
CA2375049A1 (en) * 1999-05-28 2000-12-07 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
AU5638400A (en) * 1999-06-23 2001-01-09 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
CA2392510A1 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
US6489101B1 (en) 1999-11-30 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
WO2001058947A1 (en) * 2000-02-11 2001-08-16 Corixa Corporation Lipophilin complexes for use in cancer diagnosis and therapy
AU2001253079A1 (en) * 2000-04-03 2001-10-15 Corixa Corporation Methods, compositions and kits for the detection and monitoring of breast cancer
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
WO2009014782A2 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
KR101603400B1 (ko) * 2014-02-04 2016-03-14 경상대학교산학협력단 맘마글로빈을 포함하는 암전이 억제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US573916A (en) * 1896-12-29 Threshing-machine
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) * 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
EP0856010A1 (en) * 1996-08-19 1998-08-05 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast

Similar Documents

Publication Publication Date Title
JP2001516569A5 (enExample)
JP2003528887A5 (enExample)
CA2143491A1 (en) A novel peptide related to human programmed cell death and dna encoding it
JP2004537252A5 (enExample)
JP2006501825A5 (enExample)
CA2193210A1 (en) Method of inducing an immune response with a live venezuelan equine encephalitis virus expressing a heterologous immunogen
CA2245702A1 (en) Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
CA2282300A1 (en) Recombinant pox virus for immunization against muc1 tumor-associated antigen
JP2003516731A5 (enExample)
JP2001081042A5 (enExample)
JP2002510494A5 (enExample)
JP2002505843A5 (enExample)
NZ507378A (en) Fusion proteins of mycobacterium tuberculosis antigens and their uses
CA2096159A1 (en) Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates
CA2331846A1 (en) Expression vectors for stimulating an immune response and methods of using the same
GB2143830A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
BR9712971A (pt) Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica
CA2209360A1 (en) Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
JP2004531242A5 (enExample)
DE69930630D1 (de) B2microglobulin fusionsproteine und varianten mit hoher affinität
JP2004537308A5 (enExample)
JP2002528123A5 (enExample)
CA2217522A1 (en) Isolated frpb nucleic acid molecule and vaccine
WO2001025438A3 (en) Ifn-alpha homologues
CA2010275A1 (en) Pancreatic islet cell antigens obtained by molecular cloning